The Company achieved a total revenue of $13.6 million.Gross Profit Margins continue to demonstrate a solid performance with 30% growth year-over-year.SG&A achieves a significant reduction, reflecting the Company’s notable 32% decrease year-over-year.EBITDA improves by 70% for the quarter and 65% year-over-year, reflecting progress toward profitability.Management will host a conference call on November 29, 2024, at 10 a.m. Eastern Time. TORONTO, Nov. 29, 2024 (GLOBE NEWSWIRE) — Entourage Health
Health